Our immunohistochemical analyses did by and large not identify differences in intratumoral CD8+ T cells between the treatment arms (see Fig. 6d), even though there exist multiple studies associating higher CD8+ counts with prolonged survival of glioblastoma patients58–60. Here, CD8A is linked to glioblastoma.